Doç. Dr. Atakan Topçu

• Breast Neoplasms 6 publications
  Source: OpenAlex / PubMed MeSHView publications
• Lung Neoplasms 5 publications
• Neoplasms 4 publications
• COVID-19 3 publications
• Colorectal Neoplasms 2 publications
• Carcinoma, Non-Small-Cell Lung 2 publications
• Stomach Neoplasms 2 publications
• Glioblastoma 2 publications
• Brain Neoplasms 2 publications

Medical areas of interest stated by the doctor on the institution profile. Source: medipol.com.tr.

Experience

• 2018Marmara Üniversitesi İç Hastalıklarımedipol.com.tr
• ExperienceKartal Dr. Lütfi Kırdar Eğitim Araştırma Hastanesimedipol.com.tr
• ExperienceBezmialem Vakıf Üniversitesimedipol.com.tr

Education

• 2022Bezmialem Vakıf Üniversitesi, Tıbbi Onkolojimedipol.com.tr
• 2018Marmara Üniversitesi Tıp Fakültesi, İç Hastalıklarımedipol.com.tr
• 2013Uludağ Üniversitesi, Tıp Fakültesimedipol.com.tr

• SpecialtyMedical Oncologymedipol.com.trFrom source
• InstitutionMEDİPOL Acıbadem Bölge Hastanesimedipol.com.trFrom source
• Area of workBreast NeoplasmsExtracted from 6 publications · Model version —From source
• Publications38 publicationsOpenAlexFrom source
• Languagesİngilizcemedipol.com.trFrom source
• Last synchronised4 November 2026 20:16https://medipol.com.tr/doktorlarimiz/docdr-atakan-topcumedipol.com.tr

1. Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 Inhibitors

   Medicina, 2025

   DOI 10.3390/medicina61071279 PMID 40731908 Open-access full textSource: OpenAlex

2. Real-life data on adjuvant trastuzumab emtansine treatment in early-stage HER2-positive breast cancer: a Turkish Oncology Group study

   Anti-Cancer Drugs, 2025

   DOI 10.1097/cad.0000000000001717 PMID 40162996 1 citation (Europe PMC) Open-access full textSource: OpenAlex

3. Prevalence and co-incidence of geriatric syndromes according to the ECOG performance status in older cancer patients

   Frontiers in Medicine, 2024

   DOI 10.3389/fmed.2024.1331246 PMID 38439897 12 citations (Europe PMC) Open-access full textSource: OpenAlex

4. Cardiac safety of ribociclib evaluated with 24-hour rhythm Holter electrocardiogram

   Supportive Care in Cancer, 2024

   DOI 10.1007/s00520-024-08702-0 PMID 38976108 2 citations (Europe PMC) Open-access full textSource: OpenAlex

5. The risk of malnutrition and its clinical implications in older patients with cancer

   Aging Clinical and Experimental Research, 2023

   DOI 10.1007/s40520-023-02538-0 PMID 37644257 20 citations (Europe PMC) Source: OpenAlex

6. Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group

   The Oncologist, 2023

   DOI 10.1093/oncolo/oyad257 PMID 37676712 8 citations (Europe PMC) Open-access full textSource: OpenAlex

7. Local interventions for colorectal cancer metastases to liver and lung

   Irish Journal of Medical Science (1971 -), 2023

   DOI 10.1007/s11845-023-03340-7 PMID 36929352 3 citations (Europe PMC) Source: OpenAlex

8. Clinical and inflammation marker features of cancer patients with COVID-19: data of Istanbul, Turkey multicenter cancer patients (2020–2022)

   Current Medical Research and Opinion, 2023

   DOI 10.1080/03007995.2023.2223917 PMID 37300513 5 citations (Europe PMC) Source: OpenAlex

9. Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study

   Biomolecules and Biomedicine, 2023

   DOI 10.17305/bb.2023.9253 PMID 37289436 1 citation (Europe PMC) Open-access full textSource: OpenAlex

10. The Correlation Between Skeletal Muscle Index and Anxiety in Patients with Lung Cancer on the First Day of Chemotherapy

    Future Oncology, 2023

    DOI 10.2217/fon-2022-1200 PMID 37367530 2 citations (Europe PMC) Source: OpenAlex